Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years.

Ferris DG, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Mehlsen J, Chatterjee A, Iversen OE, Joshi A, Chu JL, Krick AL, Saah A, Das R.

Pediatrics. 2017 Dec;140(6). pii: e20163947. doi: 10.1542/peds.2016-3947.

2.
3.

Psychotic disorder due to neurosyphilis.

Hung HC, Chu JL, Lu T.

J Neuropsychiatry Clin Neurosci. 2013 Summer;25(3):E67-8. doi: 10.1176/appi.neuropsych.12090217. No abstract available.

PMID:
24026752
4.

Central serous retinopathy: an unusual cause of acute visual loss.

Chu JL, Tyberg J.

CJEM. 2013 Sep;15(5):311-3.

PMID:
23972138
5.

[Spatiotemporal dynamic fuzzy evaluation of wetland environmental pollution risk in Dayang estuary of Liaoning Province, Northeast China based on remote sensing].

Sun YG, Zhao DZ, Zhang FS, Wei BQ, Chu JL, Su X.

Ying Yong Sheng Tai Xue Bao. 2012 Nov;23(11):3180-6. Chinese.

PMID:
23431807
6.

Use of a social networking web site for recruiting Canadian youth for medical research.

Chu JL, Snider CE.

J Adolesc Health. 2013 Jun;52(6):792-4. doi: 10.1016/j.jadohealth.2012.12.002. Epub 2013 Jan 23.

PMID:
23352727
7.

[Simultaneous determination of impurities in K2CrO4 by ICP-AES].

Yu ZH, Qi T, Qu JK, Chu JL, Wang LN.

Guang Pu Xue Yu Guang Pu Fen Xi. 2009 Aug;29(8):2250-3. Chinese.

PMID:
19839350
8.

Use of GC clamps in DHPLC mutation scanning.

Wurzburger RJ, Gupta R, Parnassa AP, Jain S, Wexler JA, Chu JL, Elkon KB, Blank RD.

Clin Med Res. 2003 Apr;1(2):111-8.

9.

Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression.

Georgiev M, Agle LM, Chu JL, Elkon KB, Ashany D.

Arthritis Rheum. 2005 Jan;52(1):225-38.

10.

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.

Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB.

Arthritis Rheum. 1999 Sep;42(9):1833-42.

11.

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.

Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB.

J Clin Invest. 1999 Feb;103(3):355-63. Erratum in: J Clin Invest 1999 Apr;103(7):1099.

12.

Fas ligand expression and function in systemic lupus erythematosus.

McNally J, Yoo DH, Drappa J, Chu JL, Yagita H, Friedman SM, Elkon KB.

J Immunol. 1997 Nov 1;159(9):4628-36.

PMID:
9379065
13.

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB.

N Engl J Med. 1996 Nov 28;335(22):1643-9.

14.

Transcorneal erbium laser sclerostomy: towards a guarded laser sclerostomy technique.

Shields SR, Netland PA, Chu JL, Cotran PR, Kalina PH.

J Glaucoma. 1995 Dec;4(6):391-7.

PMID:
19920705
15.

Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus.

Silverman ED, Buyon J, Laxer RM, Hamilton R, Bini P, Chu JL, Elkon KB.

Clin Exp Immunol. 1995 Jun;100(3):499-505.

16.

Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.

Chu JL, Ramos P, Rosendorff A, Nikolić-Zugić J, Lacy E, Matsuzawa A, Elkon KB.

J Exp Med. 1995 Jan 1;181(1):393-8.

17.

Enhancement of filtration surgery with cytosine arabinoside and reversal of toxicity with 2'-deoxycytidine.

Chu JL, Shields SR, Netland PA.

Curr Eye Res. 1994 Nov;13(11):839-43.

PMID:
7851120
18.

Femoro-arterial bypass using Gott shunt in liver transplantation following severe hepatic trauma.

Lin PJ, Jeng LB, Chen RJ, Kao CL, Chu JL, Chang CH.

Int Surg. 1993 Oct-Dec;78(4):295-7.

PMID:
8175255
19.
20.
21.
22.

Epitope mapping of recombinant HeLa SmB and B' peptides obtained by the polymerase chain reaction.

Elkon KB, Hines JJ, Chu JL, Parnassa A.

J Immunol. 1990 Jul 15;145(2):636-43.

PMID:
1694885
23.
24.
25.
26.

Lupus anti-ribosomal P peptide antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses.

Bonfa E, Chu JL, Brot N, Elkon KB.

Clin Immunol Immunopathol. 1987 Oct;45(1):129-38.

PMID:
3113787
27.

Spectrotypic analysis of IgM and IgA rheumatoid factors.

Chu JL, Gharavi AE, Elkon KB.

Clin Exp Immunol. 1986 Mar;63(3):601-7.

28.
30.

[Lessons from Soviet medicine in the past 10 years].

CHU JL.

Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1959 Oct;5:322-5. Chinese. No abstract available.

PMID:
13810174

Supplemental Content

Support Center